Investigating how phosphoinositide signaling affects cell functions and cancer.
Phosphoinositide Signaling in Cytosol and Nucleus
This study is looking at how certain signals in our cells can affect important processes like growth and survival, which could help us understand and treat diseases like cancer and neurodegenerative disorders.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project ID | NIH-11011518 on NIH RePORTER |
What this research studies
This research explores the mechanisms of phosphoinositide (PI) signaling in both the cytosol and nucleus, which are crucial for understanding various diseases, including cancer and neurodegenerative disorders. By examining how different agonists activate the PI3Kα pathway, the study aims to uncover how these signals control essential cellular functions such as growth, survival, and stress responses. The research employs advanced techniques to analyze the spatial and temporal dynamics of PI signaling, focusing on its role in DNA repair and cell viability. Patients may benefit from insights gained into how these pathways can be targeted for therapeutic interventions.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with cancers or neurodegenerative disorders linked to phosphoinositide signaling.
Not a fit: Patients with conditions unrelated to phosphoinositide signaling or those not affected by cancer or neurodegenerative disorders may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for treating cancers and other diseases by targeting specific signaling pathways.
How similar studies have performed: Previous research has shown promising results in targeting PI signaling pathways for cancer treatment, indicating that this approach has potential for success.
Where this research is happening
Madison, United States
- University of Wisconsin-Madison — Madison, United States (Active)
Researchers
- Principal investigator: Anderson, Richard a. — University of Wisconsin-Madison
- Study coordinator: Anderson, Richard a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.